[Usefulness of 2-mercaptoethanol sodium sulfonate (Mesnum) in the prevention of hemorrhagic cystitis in patients undergoing bone marrow transplantation].
D000741:Anemia, Aplastic / Q000628:therapy; D016026:Bone Marrow Transplantation; D003520:Cyclophosphamide / Q000009:adverse effects; D003556:Cystitis / Q000139:chemically induced / Q000517:prevention & control*; D005440:Fluid Therapy; D005665:Furosemide / Q000627:therapeutic use; D006470:Hemorrhage / Q000517:prevention & control; D006801:Humans; D007938:Leukemia / Q000628:therapy; D008623:Mercaptoethanol / Q000031:analogs & derivatives*; D015080:Mesna / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000517:prevention & control*
D008623:Mercaptoethanol; D005665:Furosemide; D003520:Cyclophosphamide; D015080:Mesna
Eficacia del 2-mercaptoetanol sulfonato sódico (Mesnum) en la profilaxis de la cistitis hemorrágica en pacientes sometidos a trasplante de medula ósea.